Dare Bioscience, Inc. Accrued Liabilities, Current
Dare Bioscience, Inc. (DARE) had Accrued Liabilities, Current of $448.94 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $448.94K.
- 2026-03-31: Accrued Liabilities, Current $529.33K.
- 2025-12-31: Accrued Liabilities, Current $725.18K.
- 2025-09-30: Accrued Liabilities, Current $2.32M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $448.94K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $529.33K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $725.18K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $2.32M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.52M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.77M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $3.04M 10-K · filed 2026-03-26 |
| 2024-09-30 | $1.85M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.25M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.37M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.89M 10-K · filed 2025-03-31 |
| 2023-09-30 | $5.29M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.19M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $5.48M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $10.89M 10-K · filed 2024-03-28 |
| 2022-09-30 | $4.14M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.35M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.54M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.14M 10-K · filed 2023-03-30 |
| 2021-09-30 | $3.78M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.37M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.52M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $3.36M 10-K · filed 2022-03-31 |
| 2020-09-30 | $2.45M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.64M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.69M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $2.10M 10-K · filed 2021-03-30 |
| 2019-09-30 | $1.54M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.34M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $690.83K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $631.35K 10-K · filed 2020-03-27 |
| 2017-12-31 | $658.43K 10-K · filed 2019-04-01 |
| 2017-06-30 | $189.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $3.54M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $4.61M 10-Q · filed 2017-08-14 |
| 2016-09-30 | $5.92M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $4.85M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $5.56M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $6.46M 10-K/A · filed 2017-06-13 |
| 2015-09-30 | $4.40M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $3.36M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $2.74M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $3.65M 10-K · filed 2016-03-10 |
| 2014-09-30 | $1.57M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $2.11M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $1.49M 10-Q · filed 2014-05-27 |
| 2013-12-31 | $2.27M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |